{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:52:35Z","timestamp":1790103155897,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR5039\/SPD\/11\/1395\/2012"],"award-info":[{"award-number":["BT\/PR5039\/SPD\/11\/1395\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11010-022-04403-6","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T23:02:20Z","timestamp":1647385340000},"page":"1765-1774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biochemical markers in the pathogenesis of preeclampsia: novel link between placental growth factor and interleukin-6"],"prefix":"10.1007","volume":"477","author":[{"given":"Rahul","family":"Negi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vemanamanda","family":"Haritha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuzhat","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-674X","authenticated-orcid":false,"given":"Athar H.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"4403_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1081\/PRG-120016792","volume":"41","author":"JM Roberts","year":"2003","unstructured":"Roberts JM, Pearson G, Cutler J, Lindheimer MD (2003) National Heart Lung and Blood Institute. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41:437\u2013445. https:\/\/doi.org\/10.1081\/PRG-120016792","journal-title":"Hypertension"},{"key":"4403_CR2","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592\u20131594. https:\/\/doi.org\/10.1126\/science.1111726","journal-title":"Science"},{"key":"4403_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785\u2013799. https:\/\/doi.org\/10.1016\/S0140-6736(05)17987-2","journal-title":"Lancet"},{"key":"4403_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1056\/NEJMe068161","volume":"355","author":"MD Lindheimer","year":"2006","unstructured":"Lindheimer MD, Umans JG (2006) Explaining and predicting preeclampsia. N Engl J Med 355:1056\u20131058. https:\/\/doi.org\/10.1056\/NEJMe068161","journal-title":"N Engl J Med"},{"key":"4403_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s0029-7844(00)01223-0","volume":"97","author":"AP MacKay","year":"2001","unstructured":"MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533\u2013538. https:\/\/doi.org\/10.1016\/s0029-7844(00)01223-0","journal-title":"Obstet Gynecol"},{"key":"4403_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","volume":"5","author":"BC Young","year":"2010","unstructured":"Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol Mech Dis 5:173\u2013192. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102149","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"4403_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2215\/CJN.03761106","volume":"2","author":"M Hladunewich","year":"2007","unstructured":"Hladunewich M, Karumanchi SA, Lafayette R (2007) Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2:543\u2013549. https:\/\/doi.org\/10.2215\/CJN.03761106","journal-title":"Clin J Am Soc Nephrol"},{"key":"4403_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bpobgyn.2010.10.012","volume":"25","author":"Y Khong","year":"2011","unstructured":"Khong Y, Brosens I (2011) Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 25:301\u2013311. https:\/\/doi.org\/10.1016\/j.bpobgyn.2010.10.012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"4403_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ogc.2010.02.013","volume":"37","author":"M Silasi","year":"2010","unstructured":"Silasi M, Cohen B, Karumanchi SA, Rana S (2010) Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 37:239\u2013253. https:\/\/doi.org\/10.1016\/j.ogc.2010.02.013","journal-title":"Obstet Gynecol Clin North Am"},{"key":"4403_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649\u2013658. https:\/\/doi.org\/10.1172\/JCI17189","journal-title":"J Clin Invest"},{"key":"4403_CR11","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","volume":"57","author":"SE Maynard","year":"2005","unstructured":"Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA (2005) Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 57:1R. https:\/\/doi.org\/10.1203\/01.PDR.0000159567.85157.B7","journal-title":"Pediatr Res"},{"key":"4403_CR12","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Lam C, Qian C et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New Engl J Med 355:992\u20131005. https:\/\/doi.org\/10.1056\/NEJMoa055352","journal-title":"New Engl J Med"},{"key":"4403_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. New Eng J Med 350:672\u2013683. https:\/\/doi.org\/10.1056\/NEJMoa031884","journal-title":"New Eng J Med"},{"key":"4403_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048259","volume":"7","author":"S Rana","year":"2012","unstructured":"Rana S, Cerdeira AS, Wenger J (2012) Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS ONE 7:e48259. https:\/\/doi.org\/10.1371\/journal.pone.0048259","journal-title":"PLoS ONE"},{"key":"4403_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1247\/csf.26.25","volume":"26","author":"M Shibuya","year":"2001","unstructured":"Shibuya M (2001) Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26:25\u201335. https:\/\/doi.org\/10.1247\/csf.26.25","journal-title":"Cell Struct Funct"},{"key":"4403_CR16","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1161\/01.cir.101.20.2382","volume":"101","author":"R Dechend","year":"2000","unstructured":"Dechend R, Homuth V, Wallukat G et al (2000) AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101:2382\u20132387. https:\/\/doi.org\/10.1161\/01.cir.101.20.2382","journal-title":"Circulation"},{"key":"4403_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/HYPERTENSIONAHA.109.140061","volume":"55","author":"AH Siddiqui","year":"2010","unstructured":"Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y (2010) Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 55:386\u2013393. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.140061","journal-title":"Hypertension"},{"key":"4403_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm.1856","volume":"14","author":"CC Zhou","year":"2008","unstructured":"Zhou CC, Zhang Y, Irani RA et al (2008) Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 14:855\u2013862. https:\/\/doi.org\/10.1038\/nm.1856","journal-title":"Nat Med"},{"key":"4403_CR19","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","volume":"123","author":"CE Powe","year":"2011","unstructured":"Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123:2856\u20132869. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.853127","journal-title":"Circulation"},{"key":"4403_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/HYPERTENSIONAHA.114.04439","volume":"65","author":"NF Parchim","year":"2015","unstructured":"Parchim NF, Wang W, Iriyama T et al (2015) Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia. Hypertension 65:430\u2013439. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04439","journal-title":"Hypertension"},{"key":"4403_CR21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3109\/14767051003774942","volume":"23","author":"M Tosun","year":"2010","unstructured":"Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalio\u011flu E (2010) Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-\u03b1 in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med 23:880\u2013886. https:\/\/doi.org\/10.3109\/14767051003774942","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4403_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/908649","volume":"2010","author":"N Vitoratos","year":"2010","unstructured":"Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G (2010) Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediat Inflamm 2010:908649. https:\/\/doi.org\/10.1155\/2010\/908649","journal-title":"Mediat Inflamm"},{"key":"4403_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/10641955.2013.835820","volume":"33","author":"K Wallace","year":"2014","unstructured":"Wallace K, Morris R, Kyle PB et al (2014) Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome. Hypertens Pregnancy 33:41\u201354. https:\/\/doi.org\/10.3109\/10641955.2013.835820","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"4403_CR24","doi-asserted-by":"publisher","first-page":"174.e1","DOI":"10.1016\/j.ajog.2007.03.058","volume":"197","author":"CJ Robinson","year":"2007","unstructured":"Robinson CJ, Johnson DD (2007) Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol 197(2):174.e1-174.e5. https:\/\/doi.org\/10.1016\/j.ajog.2007.03.058","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4403_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/10641950902968684","volume":"29","author":"SE Maynard","year":"2010","unstructured":"Maynard SE, Moore Simas TA, Bur L, Crawford SL, Solitro MJ, Meyer BA (2010) Soluble endoglin for the predic-tion of preeclampsia in a high risk cohort. Hypertens Pregnancy 29(3):330\u2013341. https:\/\/doi.org\/10.3109\/10641950902968684","journal-title":"Hypertens Pregnancy"},{"key":"4403_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11906-018-0828-4","volume":"20","author":"JP Granger","year":"2018","unstructured":"Granger JP, Spradley FT, Bakrania BA (2018) The endothelin system: a critical player in the pathophysiology of preeclampsia. Curr Hypertens Rep 20:32. https:\/\/doi.org\/10.1007\/s11906-018-0828-4","journal-title":"Curr Hypertens Rep"},{"key":"4403_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger J, Karumanchi SA (2019) Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 124:1094\u20131112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313276","journal-title":"Circ Res"},{"key":"4403_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.HYP.0000251522.18094.d4","volume":"49","author":"AM Germain","year":"2007","unstructured":"Germain AM, Romanik MC, Guerra I et al (2007) Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 49:90\u201395. https:\/\/doi.org\/10.1161\/01.HYP.0000251522.18094.d4","journal-title":"Hypertension"},{"key":"4403_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA","volume":"66","author":"FC Brownfoot","year":"2015","unstructured":"Brownfoot FC, Tong S, Hannan NJ (2015) Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia. Hypertension 66:687\u2013697. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA","journal-title":"Hypertension"},{"key":"4403_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.111.173328","volume":"59","author":"W Zhang","year":"2012","unstructured":"Zhang W, Wang W, Yu H et al (2012) Interleukin 6 underlies angiotensin II\u2013induced hypertension and chronic renal damage. Hypertension 59:136\u2013144. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.173328","journal-title":"Hypertension"},{"key":"4403_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/CS20110097","volume":"122","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Stepan H, Dechend R (2012) Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond) 122:43\u201352. https:\/\/doi.org\/10.1042\/CS20110097","journal-title":"Clin Sci (Lond)"},{"issue":"89","key":"4403_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2016.01.168","volume":"215","author":"K Baltajian","year":"2016","unstructured":"Baltajian K, Bajracharya S, Salahuddin S et al (2016) Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Am J Obstet Gynecol 215(89):e1-89. https:\/\/doi.org\/10.1016\/j.ajog.2016.01.168","journal-title":"Am J Obstet Gynecol"},{"key":"4403_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","volume":"125","author":"S Rana","year":"2012","unstructured":"Rana S, Powe CE, Salahuddin S et al (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125:911\u2013919. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.054361","journal-title":"Circulation"},{"key":"4403_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","volume":"67","author":"A Makris","year":"2016","unstructured":"Makris A, Yeung KR, Lim SM et al (2016) Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates. Hypertension 67:1263\u20131272. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07286","journal-title":"Hypertension"},{"issue":"287","key":"4403_CR35","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2013.01.016","volume":"208","author":"T Chaiworapongsa","year":"2013","unstructured":"Chaiworapongsa T, Romero R, Korzeniewski SJ et al (2013) Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol 208(287):e1-287. https:\/\/doi.org\/10.1016\/j.ajog.2013.01.016","journal-title":"Am J Obstet Gynecol"},{"key":"4403_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14767050802034545","volume":"21","author":"O Erez","year":"2008","unstructured":"Erez O, Romero R, Espinoza J et al (2008) The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 21:279\u2013287. https:\/\/doi.org\/10.1080\/14767050802034545","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4403_CR37","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642\u2013649. https:\/\/doi.org\/10.1038\/nm1429","journal-title":"Nat Med"},{"key":"4403_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol 15:275\u2013289. https:\/\/doi.org\/10.1038\/s41581-019-0119-6","journal-title":"Nat Rev Nephrol"},{"key":"4403_CR39","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335:974. https:\/\/doi.org\/10.1136\/bmj.39335.385301.BE","journal-title":"BMJ"},{"key":"4403_CR40","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.2215\/CJN.10641012","volume":"8","author":"MK Sandvik","year":"2013","unstructured":"Sandvik MK, Hallan S, Svarstad E, Vikse BE (2013) Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol 8:1126\u20131134. https:\/\/doi.org\/10.2215\/CJN.10641012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04403-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T05:15:15Z","timestamp":1651641315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4403"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04403-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ethics no: UH\/IEC\/11\/16-(R-1) (Athar H Siddiqui) and EC Ref # 1_2012 R1.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}